Using innovative nanotechnologies, an EU-funded project is developing more efficient and sustainable vaccine manufacturing processes.
Commission awards a €1 million Horizon prize to a solution that saves lives of mothers and their newborn
The Horizon Birth Day Prize was awarded yesterday, 13 February 2018, to three solutions that aim at preventing deaths related to pregnancy and childbirth. The Prize was an initiative of the European Commission which has committed €1 million from Horizon 2020, the EU research and innovation programme. The Bill & Melinda Gates Foundation pledged another €1 million and the MSD for Mothers donated a further €500,000.
European Commission supports PRESTIGE-AF, a multi-million Euro initiative for the prevention of stroke in patients with existing heart condition
PRESTIGE-AF addresses the unmet need of best antithrombotic stroke prevention in patients with atrial fibrillation, a common heart condition which causes irregular and abnormally fast heartbeat, who have also previously had a stroke caused by bleeding in the brain.
International Epilepsy Day
Epilepsy is a chronic non-communicable disorder of the brain characterised by recurrent episodes of involuntary movement known as seizures. Over the last decade, the EU dedicated nearly EUR 176 million to epilepsy research in order to advance diagnostic tools and therapeutic interventions. This money supported 62 projects in the 7th Framework Programme and 30 projects in Horizon 2020.
Co-infections and co-morbidities: EDCTP stakeholder meeting report published
Following a stakeholder meeting at the end of 2017, the European & Developing Countries Clinical Trials Partnership (EDCTP) published today a summary report on co-infections and co-morbidities in low- and middle-income countries. Participants included 52 representatives from academic and research institutions, funding agencies, product development partnerships, industry and international organisations. There is a clear need for long-term, more integrated management of poverty-related infectious diseases and NCDs.
Submit your proposal for ICPerMed Award 'Best practice in personalised medicine'
Residents of the International Consortium for Personalised Medicine (ICPerMed) Member States are encouraged to submit their proposals showcasing examples of best practice in personalised medicine by 2 March 2018. The winners will be invited to the ICPerMed conference (20-21 November 2018, Berlin) and will have the opportunity to present their results in a plenary session. EU-funded ICPerMed works on coordinating and supporting research to develop personalised medicine approaches. Its central aim is to align and encourage joint efforts in personalised medicine research and implementation on a European and international level.
World Cancer Day
"With €2.4 billion EU funding since 2007, European cancer research has been leading personalised medicine efforts on understanding cancer biology as well as better prevention, treatment & care solutions for people in Europe and beyond." said Carlos Moedas, EU Commissioner for Research, Science and Innovation on the occasion of the World Cancer Day. In addition, The European Cancer Information System website was launched on the same day by the Joint Research Centre, the European Commission's in-house science and knowledge service. The platform allows experts and practitioners to explore geographical patterns and trends and it provides valuable information on how well national cancer programmes are actually working, and address shortcomings.
8-9 March 2018, London, United Kingdom - Second international awareness session for international regulators, academia and NGOs
15 March 2018, Brussels, Belgium - Science Café with František Štěpánek